Author Archives: James

Injecting bath salts: fact, hysteria or both?

From the New York Times – my take is the reality is probably somewhere in the middle, as usual.

When Neil Brown got high on bath salts, he took his skinning knife and slit his face and stomach repeatedly. Brown survived, but authorities say others haven’t been so lucky after snorting, injecting or smoking powders with such innocuous-sounding names as Ivory Snow, Red Dove and Vanilla Sky.

Law enforcement agents and poison control centers say the bath salts, with their complex chemical names, are an emerging menace in several U.S. states where authorities talk of banning their sale. Some say their effects can be as powerful as those of methamphetamine.

Read the full story here

AOD Clinical Services Manager DAMEC

DAMEC is seeking a suitably qualified professional for the following position. This is a full-time position, although job sharing is negotiable. Position based in SW Sydney, attractive salary package (80K) negotiable.

SELECTION CRITERIA:
Current qualification in Psychology, Social work, Nursing or
other relevant field.
Demonstrated knowledge of models of care and therapeutic
intervention
Significant practical experience in counselling

Ability to supervise and support other staff
Demonstrated knowledge in co-morbid mental health and
AOD issues
Demonstrate cultural sensitivity

Full job pack can be requested from Sarina Afa on
02 9699 3552 email: sarina@damec.org.au.

Further information on this position call Kelvin Chambers on 02 9699 3552 email: ceo@counselling.damec.org.au

Please forward your complete application with supporting documentation, addressing full selection criteria per jobpack to
Prof Jan Copeland Chairperson DAMEC PO Box 2315 Strawberry Hills NSW 2012. Closing Date 31st January 2011

Writeup of gambling seminar

From Dr Andrew Byrne:

Concord Seminar summary on gambling issues. Tuesday 3rd August 2010.

The 4th Concord Seminar of 2010, “Is pathological gambling an addiction? You bet it may or may not be!” was presented by Alex Blaszczynski, Professor of Clinical Psychology and Director of the Gambling Treatment Clinic at the School of Psychology, University of Sydney. He has written a self-help manual, “Overcoming Compulsive Gambling”. He is editor of International Gambling Studies and Assistant Regional Editor for the journal ‘Addiction’.

The presentation covered the definitions and epidemiology of problem and pathological gambling, their impacts on self and others; the multifactorial etiology of gambling problems; cognitive distortions and implications for treatment; and the “pathways” model for understanding etiology and matching treatment interventions.

While pathological gambling (PG) (recurrent gambling despite severe negative consequences and/or repeated unsuccessful attempts to cease) remains classified in DSM -IV-TR (A.P.A., 2000) among the impulse control disorders (along with kleptomania and pyromania), its diagnostic criteria since DSM III have come more closely to resemble those substance use disorders. In DS-V, it is proposed to reclassify the condition as a non-substance behavioural addiction. By contrast, ‘problem’ gambling is defined by harms to the individual player, their family and/or the wider community. This resembles the definition of harmful substance use in ICD-10.

There has been a worldwide increase of legalized forms of gambling, starting in the USA in 1968 with the New Hampshire lotteries; in Australia with the 1973 West Point Casino; in Britain with the1978 Royal Commission into Gambling and large increases in Europe in the 1990s and in Asia in 2000s. Electronic gaming machines have become increasingly common while the current spectacular growth area is in online gambling.

The prevalence of moderate to severe problem gambling is similar in Australia (2.7%) and in the USA (3.0%). Estimates vary widely for prevalence of pathological gambling (Australia 0.6-1.2%; USA 0.1-1.9%), reflecting the assessment tools used (e.g., South Oaks Gambling Screen versus DSM criteria).

The DSM diagnosis of pathological gambling (PG) requires five or more of the following:
1. Preoccupation (psychological dependence & salience)
2. Increased amount gambled (tolerance)
3. Irritability/restlessness on cessation (withdrawal)
4. Escape from stress (negative reinforcement & motivation)
5. Chasing losses (erroneous & distorted cognitions)
6. Lying
7. Repeated failure to cease (impaired control)
8. Illegal acts
9. Risked significant relationships
10. ‘Bailout’ (relatives or friends paying gambling debts)

The criteria of salience, tolerance, withdrawal, impaired control and continuing despite knowledge of harm have obvious parallels with substance dependence, and suggest the likely involvement of meso-limbic/orbito-frontal reward systems in positive and negative reinforcement, underpinning classical and operant conditioning in the development of craving, and impulsive decision-making in pathological gambling.

However, certain other features of pathological gambling bear less close comparison with substance dependence. One example is the mediating function of erroneous and distorted cognitions such as the “gambler’s fallacy”, the mistaken belief that the chances of winning over time increase (in fact the chances of winning remain the same at each point in time, and losses are cumulative over time). A recent published paper (Slutske et al 2010), reported that recovery from PG is commonly achieved in the absence of abstinence, ie with a return to “controlled gambling”, a further difference from most instances of substance dependence, where a return to controlled use is exceptional (see Stanton Peele for the contrary view for alcohol and drug use).

Indeed the significance of tolerance or withdrawal, two defining elements of “gambling as an addiction”, remains unclear. A recent study (Blaszczynski et al 2008) found that increased bet size was not related to the need to maintain excitement or arousal levels, as in an addictive model, but rather were consistent with a cognitive model in which accumulating debts coupled with erroneous perceptions lead the gambler to increase bet size, with larger bets required to win enough to meet financial obligations. While withdrawal features in gambling are comparable in severity and character (depression, general discomfort, irritability/agitation, restlessness, anxiety and headache) to alcohol withdrawal, it remains unclear whether these symptoms “result from the inability to gamble or from the loss of an avoidant stress coping strategy”.

As for substance dependence, gambling has a multifactorial etiology. There is a strong association of PG with parental gambling and genetic transmission is estimated to account for 40-54% of variance of risk for developing PG (Shah et al., 2005). Other factors include environmental factors such as access to venues, ease of accessing money, advertising, community and cultural attitudes, ethnicity and lower socioeconomic status.

In terms of comorbidity, 40% of PG have current substance use disorders, 75% suffer major depression, 40% report serious suicidal ideation. It is estimated that approximately 1.7% of Australian suicides are gambling-related. PGs score high for impulsivity, risk-taking, substance use disorders, and borderline, anti-social, narcissistic personalities. Some 60% commit illegal acts to support their habit, usually non-violent property crimes.

There are gender differences, in that men are more likely to engage in wagering and online and sports gambling; women have a bimodal distribution of young and 45yo gambling. Early onset (before age 20) is almost universal in PG, fostered by family examples of gambling, and gifts such as scratch lotteries. The average age at treatment seeking is in the mid to late 30s.

The problems associated with problem and pathological gambling are wide ranging, as the person slips into borrowing and financial strife, sometimes into theft and lying, with impacts on work, legal problems, family problems including neglect, domestic violence and family breakdown, increasing stress, worry and depression, even personality change (irritability, becoming withdrawn).

The impacts on spouses can be enormous, including loss of trust and sense of security, loss of savings, superannuation, even the marital home, or the partner forced to resume or increase work hours. Domestic violence, emotional and physical and verbal abuses are common (often against the gambler). Children of gamblers may suffer confusion, insecurity and poor self esteem, emotional neglect, exposure to domestic arguments/violence, as well as adverse role modeling and vicarious learning.

By way of example, Professor Blaszczynski drew our attention to the structural characteristics of electronic gaming machines (EGMs). They operate within a social, alcohol-licensed environment and provide continuous, rapid cycle, multi-line multi-credits, many near wins, requiring minimal skill and fostering erroneous beliefs. The random ratio schedule of reinforcement (wins) is the most resistant to extinction of all reinforcement schedules, perhaps because of the intensity of the mounting excitement and arousal created by the unpredictability of a reward. This forms an interesting contrast to substance use disorders in that the effect of most psychoactive substances is, comparatively, predictable and constant (as long as the drug supply is secure).

Professor Blaszczynski pointed to the multiple factors interacting in an etiological model for PG: neurobiological/genetic factors as with substance dependence, interacting with personality and with environmental factors including family and peer group influences, and the wider socio-cultural setting of gambling.

This model resembles the bio-psycho-social framework generally used for conceptualising substance use disorders. One distinct difference however is the central role of belief schemas that have a mediating function in the development of problem and pathological gambling. These include the “gambler’s fallacy” mentioned above, but also superstitious beliefs (rituals, talismanic objects, cognitive ‘prayers’, promises, bargaining), biased evaluation, illusions of control and belief in the role of personal skill.

Erroneous cognitions are common in pathological gamblers (PG) and non-pathological gamblers alike, although superstitious beliefs are more common in PG, and PG are more likely to show make increasing estimates of the chances of winning during a session of play. Knowledge of the statistical reality of gambling itself does not prevent irrational beliefs during play.

The approaches to reducing harms from gambling, like those for substance use disorders, range of from public health measures to psychological and pharmacological therapies. As the risk of PG increases with consumption, measures to reduce overall consumption would be expected to have benefit: as with substance use disorders, consumption is skewed, with mean higher than median, and a small number of people accounting for a large amount of consumption. Taxation revenue incentives severely impede a regulatory public-health approach to gambling problems.

Self-help groups such as Gamblers Anonymous are effective for a significant minority of people. However, drop-out rates are very high.

Cognitive therapy is beneficial in 75-80% of cases resulting in the reduction of cognitive distortions and levels of gambling behaviour, motivation and urges to gamble. This form of therapy aims to inform gamblers that gaming machines are recreational devices on which you spend money: while it is possible to win in the short-term, in the long term, in all but the most unusual cases and extraordinary circumstances, this outcome is virtually impossible.

Behavioural interventions are designed to diminish the arousal associated with gambling, and include aversive therapy, imaginal desensitization, and stimulus control and cue exposure techniques. Positive outcomes are achieved in 20%-70% of PG with reduced arousal associated with gambling stimuli and consequently diminished urges to gamble.

The posited underlying neurobiological mechanisms of gambling suggest potential benefit of psychopharmacological interventions, however studies of lithium, SSRIs, naltrexone and olanzepine have given mixed and overall disappointing results. The studies to date have been limited by small size, high drop-out rates, short follow-up and varied outcome measures.

A further problem in evaluating treatments is that PGs do not form a homogeneous group. Accordingly, Blaszczynski and Nower (2002) have proposed a “pathways model” which distinguishes among three more or less distinct groups of PG, with implications for treatment matching.

A first pathway, encompassing mainly behaviourally conditioned gamblers, is characterized by a social context of gambling, with wins generating excitement, reinforcement and cognitive distortions leading to poor decisions. These people have less dissociation and more absorption in their gambling, briefer histories and either less severe gambling or rapid escalation in response to defined stress. They have a background of childhood and family stability, with less severe psychopathology. Substance abuse onset tends to follow rather than precede gambling problems. Cognitive-behavioural interventions are most likely to be effective with this group.

For the second and third pathways and for the second half of the seminar, and references, see the web site:

http://dependencyseminars.blogspot.com/2010/11/concord-seminar-summary-on-gambling.html

http://methadone-research.blogspot.com/

Fifth Annual Conference of the International Society for the Study of Drug Policy

This is the final call for papers for the Fifth Annual Conference of the International Society for the Study of Drug Policy which will be hosted by the Trimbos Institute on 23-24 May 2011 in Utrecht, Netherlands.

This conference should be of interest to policymakers, practitioners, and academics from a wide array of disciplines who are engaged in drug policy analyses pertaining to drug markets, the harms caused by both the supply of and demand for drugs, and the intended and unintended consequences of drug policy. The goal of this conference is to share information, findings and methods as well as to facilitate collaboration among a broad set of top international scholars and policy makers.
The deadline for submission of abstracts or panel proposals is January 15, 2011. Abstracts containing between 200 and 400 words and panel proposals should be submitted to issdp@trimbos.nl. Areas of particular interest include:

· Supply reduction indicators: how to improve data and estimates of production, trafficking, wholesale or retail dealing, and money laundering
· Improving and utilizing cross-national comparisons of problems and policies
· Harm reduction principles and practices in the supply field
· Regulating regimes as alternative for prohibitionist regimes: example regulating cannabis production, wholesale distribution, and street sales
· What do drug policy evaluations produce: applicability and use of evaluations and other policy (relevant) studies
· Cost benefit analysis of policies and measures (e.g. alternatives to prison, targeting of substance abuse treatment and diversion programs for criminal offenders) paying specific attention on the issue how to measure lost welfare associated with drug prohibition
· Assessing the major influences on drug policy decision processes, including institutional, cultural and political factors, such as: political windows of opportunity (politics and political competition), institutional resources of policy-actors and advocacy groups.
Optional post-conference workshops will be held 25 May, 2011.

Further information is available at http://www.trimbos.org/trimbos-international/agenda/issdp-conference-2011

URGENT REQUEST from the Global Burden of Disease – Illicit Drug Use Expert Group

From Prof Louisa Degenhardt – Chair, Illicit Drug Use Expert Group:

We are looking for data from around the world on hepatitis B and C (HBV and HCV) prevalence among injecting drug users (IDUs). Do you have data from your country?

As part of work we are conducting for the 2010 Global Burden of Disease Study, we are undertaking a systematic review of existing data on the prevalence of HBV and HCV among injecting drug users. This work is being overseen by the Illicit Drug Use Expert Group and a team of researchers with expertise in undertaking systematic reviews (see www.gbd.unsw.edu.au). This is one of the first attempts to quantify the extent to which viral hepatitis is an issue faced by people who inject drugs on a global scale. Such estimates are crucial building blocks to inform responses to viral hepatitis at country, regional and global levels.

We are in the process of making estimates for every country around the world on:
– the prevalence of HCV among IDUs
– the prevalence of HBV among IDUs, with separate estimates for
o hepatitis B surface antigen (HBsAg)
o antibody to hepatitis B core antigen (anti-HBc)

Many of you may be familiar with the estimates that were released by the Reference Group to the UN on HIV and injecting drug use (see www.idurefgroup.com). We hope to produce a similar set of estimates for HBV and HCV. This is challenging because in many countries, data may not be widely available. We have conducted a large search of the peer-reviewed literature, and are gathering as much grey literature (such as NGO and government reports) as possible. However, there will be some material that our search would have missed.

Do you have any information that may be of use to us? Any assistance will be acknowledged in the reports we are writing on this subject. Due to the tight timelines of this project we can only consider material received by Monday 17 January 2011. Many thanks in anticipation of any information you can provide, and for circulating to other colleagues who may be able to assist.

Have a happy and safe holiday.
Paul Nelson,
on behalf of Prof Louisa Degenhardt
Chair, Illicit Drug Use Expert Group
2010 Global Burden of Disease Study
Please direct all correspondence to gbd@med.unsw.edu.au

Jobs: Research Officer/Fellow

From the Burnet Institute:

· Data linkage focused
· Excellent salary packaging benefits
The Burnet Institute is a leading Australian medical research and public health organisation focused on improving the health of disadvantaged and marginalised groups.

We are seeking to appoint a Research Officer/Fellow to work primarily on two NHMRC studies in the area of Justice Health. The studies involve following large cohorts of ex-prisoners using a combination of record linkage, face-to-face interviews, interrogation of health records and qualitative methods. Expected outputs of the research include an improved understanding of the links between patterns of healthcare utilisation and health outcomes for ex-prisoners, and quantification of the impact of opioid substitution therapy (OST; methadone or buprenorphine) on two important outcomes for opioid dependent prisoners: mortality, particularly in the post-release period; and subsequent criminal activity.

You will be responsible for:
Liaising with data custodians to obtain data for research purposes
Managing relationships with stakeholders involved in the projects
Co-ordinating investigator and stakeholder meetings
Maintaining study databases
Conducting statistical analyses of linked data sources, under the guidance of study investigators and Institute statisticians
Leading the presentation and reporting of study results under the supervision of study investigators

As a Research Fellow, you will also be responsible for:
Developing a funded program of work synergies with existing priorities of the Centre
Contributing to the development of the strategic direction of the Centre for Population Health
Disseminating research findings through presentations at conferences and publications in peer-reviewed journals

You will have:
An Honours or Masters degree in public health, epidemiology, biostatistics, social sciences or a related field
Excellent data management and statistical analyst skills
The ability to collate, analyse, interpret and report data in a variety of formats
Demonstrated experience in writing reports and preparing ethics and research grant applications
Good computer skills, especially with Access databases, Excel and Word, and with statistical software such as Stata
Demonstrated ability to work autonomously and with initiative, in challenging environments

Additional criteria for the Research Fellow include:

A PhD in public health, epidemiology, biostatistics, social sciences or a related field
Demonstrated experience in disseminating research findings through oral presentations and academic, peer-reviewed journals
Benefit from a monthly accrued day off and attractive salary packaging working for this leading not for profit organisation. Applications should be emailed to jkitch@burnet.edu.au by 24 December, 2010 . For more information and a copy of the position description, please see our website at www.burnet.edu.au/home/general/employment .

Growing Up Solid: integrating emotional and mental health throughout infancy, childhood and adolescence

From the RANZCP:

Growing Up Solid
Joint RANZCP Faculty of Child and Adolescent Psychiatry and Australian Association for Infant Mental Health Conference
Growing Up Solid: integrating emotional and mental health throughout infancy, childhood and adolescence
12 – 14 May 2011
Perth, Western Australia

The AAIMHI and RANZCP Faculty of Child Psychiatry are delighted to host a joint conference, reflecting their commitment to the integration of understanding and treatment of mental illness from infancy to adulthood, encompassing different perspectives, organisations and cultures. Guests include international visitors from South Africa (Dr Astrid Berg), USA (Dr Karlen Lyons Ruth ) and UK (Ms Michelle Sleed and Prof Robin Murray), and West Australian / Victorian artist Mr Shaun Tan.

Abstracts are welcome from people working in the alcohol and other drug sector. The closing date for submissions has been extended until Saturday 15 January 2011.

For more information, please visit:
http://www.sapmea.asn.au/conventions/aaimhi&fcap2011/index.html

A Family Sensitive Policy and Practice Toolkit

An Invitation to a Launch:
A Family Sensitive Policy and Practice Toolkit

You and your colleagues are cordially invited to a launch of an important new NCETA resource entitled A Family Sensitive Policy and Practice Toolkit addressing child protection issues for workers in the alcohol and drug area.

The toolkit has been developed by the National Centre for Education and Training on Addiction (NCETA), Flinders University as part of it collaborative partnership with, and through funding from, the SA Department of Health. Development of the toolkit resulted from the collaboration between NCETA and Professor Dorothy Scott former Director, Australian Centre for Child Protection, University of South Australia. Members of the South Australian Family Drug and Alcohol Network (FADNET) also contributed to the development of parts of the toolkit.

The toolkit is the first resource of this type to be developed in Australia and it has both national and international application. It builds upon the growing need for a more comprehensive approach to understanding the causes, prevention and treatment of alcohol and other drug problems. The primary audience is the alcohol and other drugs sector including AOD practitioners, social workers, general practitioners, mental health professionals, psychologists, community health workers, health promotion staff and those working in the legal/justice system. It is also intended for professionals working in the Family and Child Welfare/Child Protection sector.

The kit is designed to enhance evidence-based practice and facilitate Family Sensitive Policy and Practice within alcohol and other drug treatment services. It takes a holistic, public health approach to addressing alcohol and other drug misuse and aims to mitigate the impact of that misuse upon children and other family members. The Family Sensitive Policy and Practice toolkit comprises:

· For Kids’ Sake: A workforce development resource for Family Sensitive Policy and Practice in the Alcohol and Other Drugs Sector
· Taking First Steps: What Family Sensitive Practice Means for Alcohol and Other Drug Worker – A Survey Report
· A Checklist for Family Sensitive Practice for the Alcohol and other Drug Field
· Family Sensitive Practice in the Alcohol and Other Drug Field (6 page summary flyer)
· A CD-Rom containing all of the above plus additional resources in electronic format.

The toolkit will be launched by the Hon. John Hill, MP, Minister for Health and Minister for Mental Health and Substance Abuse at:
2.15pm Thursday 16 December, 2010
Flinders University City Campus
Room 1, Level 1
182 Victoria Square
Adelaide SA

Afternoon tea and copies of the toolkit will be available at the launch.
RSVP: Tuesday 14 December 2010
nceta@flinders.edu.au
or Phone: (08) 8201 7535

Please contact NCETA for a map for the venue location and parking details.

Jobs – Research Assistant, Drug Use Studies

Research Assistant, drug use studies

· Field-based work

· Excellent salary packaging benefits

· Full-time position, based on Commercial Road

The Burnet Institute is a leading Australian medical research and public health organisation focused on improving the health of disadvantaged and marginalised groups. We integrate our world-class laboratory and field-based research into multidisciplinary programs to prevent, detect and treat diseases of global significance.

We are seeking a Research Assistant to work in our Alcohol and other Drug Research Program, which is based in our Centre for Population Health. The Program involves research into the use of illicit drugs and the associated risks, and borne viruses and sexually transmitted infections and the behaviours associated with their transmission. Research methodologies include social network analysis, molecular epidemiology and mathematical modelling.

You will be part of our multidisciplinary Fieldwork Team and be involved in conducting face-to-face research on several of our ongoing studies involving people who inject drugs.

You will be responsible for:
Recruiting and maintaining contact with participants for studies based in the field, both face-to-face and via telephone
Collecting blood samples from participants
Performing other research tasks as required, such as contributing to the writing of ethics applications and reports, literature searches and reviews
Contributing to the production of research and surveillance outputs such as conference papers, reports and other publications

You will have:
Excellent communication and interpersonal skills
Knowledge of the issues facing vulnerable populations
A flexible approach to your work
Intermediate computer skills, especially with Access databases, Excel and Word
Health science and/or public health or social work degree, ideally with experience in conducting interviews and data entry (desirable)
Experience in writing reports and preparing ethics and research grant applications (desirable)

Benefit from a monthly accrued day off and attractive salary packaging working for this leading not for profit organisation. Applications should be emailed to jkitch@burnet.edu.au by 13 December 2010 . For more information and a copy of the position description, please see our website at www.burnet.edu.au/home/general/employment .

Jobs: HealthLink Telephone Counsellor .5 Melbourne

HealthLink Telephone Counsellor .5
Turning Point Alcohol & Drug Centre
Eastern Health

• Fitzroy Location, Melbourne, Victoria
• Salary Packaging Available

HealthLink currently has a vacancy for a part time counsellor. The position is responsible for the provision of high quality telephone and/or web based assessment, counselling, referral and consultancy services to the general public and health professionals across the service network of Telephone/Web Based Services. This may include services associated with alcohol and drugs and/or the problem gambling area. Intervention is provided within a harm minimization framework.

The successful candidate will possess a Certificate IV in AOD, or completing a tertiary degree with relevant AOD experience. Compliance with DHS minimum qualification strategy will be highly regarded. A knowledge and demonstrated capacity of contemporary treatment interventions and support to persons affected by alcohol and other drugs and/or problem gambling is required. This is combined with your superior communication and interpersonal skills, demonstrated capacity to work with people from diverse cultural and linguistic backgrounds and strong commitment to high quality service. Experience in telephone/web counselling will be highly regarded.

This is a Part time position which requires working two overnight shifts and one day shift per fortnight.

Enquires: Marlyn Gavaghan, marling@turningpoint.org.au, 9418 1037
Applications to be made on line: www.easternhealth.org.au/careers, reference number 89056